SCA
AGN

Strategic Capital Alternatives’s Allergan Inc AGN Stock Holding History

Strategic Capital Alternatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-515
Closed -$92K – 418
2014
Q3 		$92K Buy
+515
New +$85.5K 0.03% 176

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Strategic Capital Alternatives's AGN Position: Q4 2014 in Review

Strategic Capital Alternatives sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 515 shares — an estimated $92K sold.

Strategic Capital Alternatives first reported a position in AGN in Q3 2014 and held it in 1 quarter. The position peaked at $92K in Q3 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Strategic Capital Alternatives reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Strategic Capital Alternatives sold 515 Allergan Inc shares in Q4 2014, an estimated $92K.
  • Strategic Capital Alternatives first reported a position in Allergan Inc in Q3 2014 and held it in 1 quarter.
  • Strategic Capital Alternatives's Allergan Inc position peaked at $92K in Q3 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Strategic Capital Alternatives's 13F filing for Q4 2014, filed 18 Feb 2015.